LLOYD BENJAMIN: Open Payments
NPI 1811970072 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 44 payments from 8 companies in 2025. Trend: 2023 $669 · 2024 $1,029 · 2025 $872
Food & beverage: $799Education: $73
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $184 |
| Otsuka America Pharmaceutical, Inc. | 12 | $168 |
| Neurocrine BioSciences, Inc. | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 3 | $90 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: CAPLYTA, REXULTI, INGREZZA, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, AUSTEDO XR, FANAPT.
Industry payments across CA — which companies pay providers there.
